{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-21-001498","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2021-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.585331+00:00","generated_at":"2026-06-29T04:06:12.131969+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Anavex presents at H.C. Wainwright conference; no material new information filed","bullets":["Presented corporate deck at H.C. Wainwright 23rd Annual Global Investment Conference on Sep 13, 2021.","CEO Christopher Missling delivered the presentation via webcast.","No financial results, pipeline updates, or guidance disclosed in the 8-K filing.","Exhibit 99.1 investor presentation is furnished but not filed with the SEC.","Filing is a Regulation FD disclosure without substantive operational details."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-21-001498","json":"https://secwatch.observer/filing/0001731122-21-001498.json","markdown":"https://secwatch.observer/filing/0001731122-21-001498.md","text":"https://secwatch.observer/filing/0001731122-21-001498.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001498/0001731122-21-001498-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001498/e3088_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T04:06:12.131969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}